Nigeria has hundreds of universities, polytechnics, specialised research institutes and thousands of academics producing research every year.
Theses are defended.
Papers are published.
Conferences are held.
Government research grants are awarded.
Laboratories create prototypes.
Yet ask a simple question: how many major Nigerian companies can be traced directly to research commercialised from a Nigerian university laboratory?
The list becomes short very quickly.
This week, the National Office for Technology Acquisition and Promotion is again trying to move the conversation forward through the National Technology and Innovation Summit, built around the theme “From Research to Wealth”.
The phrase is exactly right.
Research creates knowledge.
Commercialisation converts useful knowledge into products, services, licences, spin-out companies and jobs.
Nigeria's problem is not that nothing is invented.
It is that the bridge from invention to market is weak.
Research and commercialisation are different activities
A good academic paper is not automatically a good business.
A researcher may prove that a technology works in a laboratory.
A customer cares whether it works consistently, safely and affordably outside the laboratory.
A university may reward publication.
An investor cares about market size, intellectual-property ownership, team capability and return.
A scientist may want technical perfection.
A business may need a simpler version that customers will actually buy.
Commercialisation therefore requires translation.
That translation needs people and institutions designed for it.
Nigeria has already created technology-transfer offices
The country is not starting from zero.
NOTAP has supported Intellectual Property and Technology Transfer Offices in universities and research institutions.
These offices are supposed to help researchers identify intellectual property, protect inventions and connect research with industry.
WIPO and Nigerian institutions have also run programmes aimed at strengthening research commercialisation and university spin-outs.
The problem is uneven capacity.
A technology-transfer office can exist on an organisational chart without having enough patent expertise, industry relationships, market-analysis skills or commercial funding.
The office needs professional capability, not only a name.
The first weakness is often the research question itself
Commercialisation becomes easier when research begins with a real problem.
This does not mean every academic project should be commercial.
Fundamental research matters.
Humanities research matters.
Knowledge has value beyond immediate profit.
But where the objective is innovation, researchers should engage industry earlier.
What problem is a manufacturer trying to solve?
What disease is difficult to diagnose cheaply?
What agricultural process wastes the most money?
What imported industrial input could be localised?
When research begins with a user, the path to market is shorter.
Universities and companies speak different languages
Academics talk about novelty, methodology and publication.
Companies talk about cost, reliability, customers and competitive advantage.
Neither language is wrong.
The problem is translation.
Nigeria needs more people who understand both.
Technology-transfer professionals, product managers, industry fellows and entrepreneur-scientists can connect the two worlds.
A professor should not have to become a full-time salesperson.
The institution should have people who can explain the technology to investors and companies.
Intellectual-property rules need to be clear before money arrives
One of the fastest ways to destroy a university spin-out is to argue about ownership after the business becomes valuable.
Who owns the patent?
The university?
The researcher?
The funding agency?
A private collaborator?
What percentage does the inventor receive if the university licenses the technology?
Can the researcher own shares in a spin-out?
What happens if graduate students contributed?
These questions should be answered by policy before commercialisation begins.
Every university should publish an understandable IP and revenue-sharing framework.
Researchers are more likely to disclose inventions when they know they will share fairly in the value created.
Patents are not the same as commercial success
Nigeria sometimes celebrates the number of patents filed.
Patents can be useful.
They protect novelty and can increase investor confidence.
But a patent that nobody licenses has limited economic effect.
The objective is not patent accumulation.
It is technology adoption.
A university should therefore measure licences signed, spin-outs created, external investment attracted, industry-funded projects and revenue from intellectual property.
Those are better commercialisation indicators.
Prototype funding is a major missing middle
Research grants often finance discovery.
Venture investors usually want evidence that a product can reach a market.
Between these stages sits a difficult financing gap.
A prototype may need redesign.
Regulatory tests may be required.
Manufacturing methods must be developed.
Customers need pilots.
This stage is too commercial for a pure academic grant and too early for many investors.
Nigeria needs proof-of-concept and translational funds specifically designed for this gap.
They should release money against technical and market milestones.
Researchers need entrepreneurial partners
The person who invented a technology is not always the person who should run the company.
This is normal.
A scientist may prefer research.
A commercial founder may be stronger at hiring, sales and fundraising.
Universities should create mechanisms that match researchers with entrepreneurs.
Business schools can help.
Alumni networks can help.
Startup accelerators can help.
The spin-out team should be built around complementary skills rather than academic hierarchy.
Venture capital is not suitable for every research business
The startup conversation often assumes every new company should raise venture capital.
That is not true.
Some university technologies may be better licensed to an existing manufacturer.
Some need strategic corporate investment.
Some need patient development finance.
Some can grow from customer revenue.
A medical technology with long regulatory timelines has different financing needs from a software company.
Commercialisation policy should offer several pathways.
Industry should spend more money inside universities
One of the strongest innovation systems is industry-funded research.
A company brings a problem and money.
A university brings expertise, facilities and researchers.
The resulting intellectual property is governed by a clear contract.
Nigeria has examples of industry collaboration, but not at the scale its economy needs.
Companies often prefer importing technology because local research feels uncertain or slow.
Universities often complain that industry does not trust them.
Both sides need structured partnerships with service standards and timelines.
Procurement can become the first customer
A technology can be commercially promising and still fail because nobody wants to be the first buyer.
Government can solve some of this through innovation procurement.
If a Nigerian university develops a credible medical device, agricultural technology or public-service software, a public agency can run a transparent pilot.
The purpose is not to force government to buy inferior products.
It is to create a pathway for proven local innovation to demonstrate performance.
Once a technology has a reference customer, private buyers become more confident.
Regulation should be involved earlier
Health, food, energy and financial technologies often require regulatory approval.
Researchers may spend years developing something only to discover late that the regulatory pathway is difficult.
Regulators should therefore create early advisory channels for university innovations.
NAFDAC, SON, NCC, NERC and other agencies can help inventors understand requirements before expensive design choices are fixed.
This reduces wasted research.
Universities need commercialisation professionals with market incentives
Technology transfer should not be treated as an administrative posting.
The people doing it need skills in IP, licensing, valuation, industry engagement and venture creation.
Universities may need to recruit from outside academia.
Compensation should reflect performance.
A successful licensing officer who helps create millions of naira in revenue should have a career path.
Without professional incentives, commercialisation offices become paperwork centres.
Academic promotion systems need adjustment
Researchers respond to what institutions reward.
If promotion depends overwhelmingly on publications, academics will publish.
If patents, prototypes, licences, industry projects and successful spin-outs count meaningfully, behaviour will diversify.
This does not mean lowering academic standards.
It means recognising innovation as a legitimate form of scholarly impact.
A university should be proud when research becomes a company as well as when it becomes a journal article.
Students can become a major commercialisation force
Many university startups globally emerge from students and young researchers.
They have time, ambition and fewer institutional constraints.
Nigerian universities should build entrepreneurship programmes around real campus technologies rather than generic business-plan competitions.
Engineering students can work with medical researchers.
Business students can test markets.
Law students can support IP clinics.
Design students can improve usability.
This creates a university innovation ecosystem rather than isolated research projects.
TETFund and research grants should include commercial pathways
TETFund's National Research Fund and research fairs already support research activity and innovation visibility.
The next step is a structured path after the grant.
Every commercially relevant project should answer a few questions near completion.
What is the technology-readiness level?
Who is the potential customer?
What IP exists?
What testing remains?
What funding is needed to reach market?
This information can feed a national commercialisation pipeline.
Nigeria needs a searchable national research marketplace
Investors and manufacturers should be able to search Nigerian innovations in one place.
The database should show institution, inventor, problem addressed, technology readiness, IP status, evidence, commercial pathway and contact point.
Confidential technical details can remain protected.
The objective is discoverability.
A manufacturer cannot license a technology it does not know exists.
Universities should be allowed to own equity efficiently
When a university spin-out is created, the institution may receive equity in exchange for IP.
The governance needs to be simple enough that future investors are not trapped in bureaucracy.
Universities should not try to control every decision in a startup.
They should protect public value while allowing the company to operate commercially.
Standard spin-out agreements would help.
Failure must be acceptable
Commercialisation includes risk.
Not every invention will become a successful product.
Not every spin-out will survive.
If institutions punish every failed attempt, researchers will avoid entrepreneurship.
The correct approach is disciplined experimentation.
Projects should have milestones.
Funding should stop when evidence is weak.
But honest failure should produce learning rather than scandal.
The summit should be judged six months later
The National Technology and Innovation Summit is useful if it produces transactions.
How many researchers met investors?
How many licensing discussions began?
How many prototypes received funding?
How many industry partnerships were signed?
How many were still active six months later?
Those are better measures than attendance and speeches.
Nigeria does not need another conference that celebrates innovation without commercial outcomes.
The country has enough research to begin building companies now
Nigeria will always need more research funding and better laboratories.
But lack of perfection should not become an excuse.
There are already researchers with useful technologies.
There are already companies that need solutions.
There are already investors looking for opportunities.
The missing infrastructure is connection, incentives and professional translation.
The question “Where are the companies?” should therefore become a national innovation metric.
A university is not a factory, and it should not be judged only by businesses created.
But when a country funds research in agriculture, health, engineering, software and energy, some of that knowledge should reach the market.
Research becomes wealth when someone can use it, pay for it and scale it.
Nigeria's innovation policy will mature when that journey becomes normal rather than exceptional.
Sources and further reading
- NOTAP/ThisDay, July 2026: National Technology and Innovation Summit and research-commercialisation agenda
- WIPO Nigeria, March 2026: Scale Up Your IP and university research commercialisation workshop
- University of Nigeria Intellectual Property and Technology Transfer Office: mandate and background
- TETFund National Research Fund and 2026 Research-to-Market fair
A. Joshua Adedeji
A. Joshua Adedeji is a leadership strategist, organisational development consultant, author, teacher and values-driven transformation leader. He writes on leadership, strategy, governance, organisational effectiveness, business, personal development and Nigeria’s social and economic transformation, connecting ideas and current realities to practical implications for leaders, institutions, entrepreneurs and citizens. His work is shaped by a commitment to clear thinking, responsible leadership, stronger institutions and the development of people and systems capable of producing lasting impact.
Reader conversation
0 approved comments